Mr. Tan is the Chief Financial Officer & Treasurer of Solid Biosciences and leads all financial functions, corporate communications and investor relations.
Mr. Tan has served as the Chief Financial Officer of Solid Biosciences since January 2023.
From September 2021 to November 2022, Mr. Tan was Chief Financial Officer at Selecta Biosciences Inc., a biopharmaceutical company. While there, he led all financial functions, business development, corporate communications, and investor relations. From May 2018 to September 2021, Mr. Tan held positions of increasing responsibility at Sarepta Therapeutics, Inc., a precision genetic medicine company. He was a key member of the Business Development team and ultimately served as Treasurer of the organization. Prior to Sarepta, Kevin had a long career in financial services most recently as Senior Portfolio Manager at CPP Investments, the national pension fund of Canada. Prior to CPP Investments, Kevin worked in capital markets roles at Macquarie Capital and Lehman Brothers and in Mergers & Acquisitions at UBS Investment Bank.
Mr. Tan received a Bachelors of Commerce from Queen’s University at Kingston, a Masters Degree in Engineering in Operations Research and Financial Engineering from Princeton University and an MBA from The University of Chicago Booth School of Business. Mr. Tan is a Chartered Financial Analyst.
What is Kevin Tan's net worth?
The estimated net worth of Kevin Tan is at least $686.01 thousand as of February 18th, 2026. Mr. Tan owns 99,422 shares of Solid Biosciences stock worth more than $686,012 as of May 6th. This net worth evaluation does not reflect any other investments that Mr. Tan may own. Learn More about Kevin Tan's net worth.
How do I contact Kevin Tan?
Has Kevin Tan been buying or selling shares of Solid Biosciences?
Kevin Tan has not been actively trading shares of Solid Biosciences during the past quarter. Most recently, Kevin Tan sold 5,404 shares of the business's stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $5.82, for a transaction totalling $31,451.28. Following the completion of the sale, the chief financial officer now directly owns 99,422 shares of the company's stock, valued at $578,636.04. Learn More on Kevin Tan's trading history.
Who are Solid Biosciences' active insiders?
Are insiders buying or selling shares of Solid Biosciences?
During the last twelve months, insiders at the sold shares 32 times. They sold a total of 623,491 shares worth more than $3,950,941.46. The most recent insider tranaction occured on February, 18th when CFO Kevin Tan sold 5,404 shares worth more than $31,451.28. Insiders at Solid Biosciences own 13.6% of the company.
Learn More about insider trades at Solid Biosciences. Information on this page was last updated on 2/18/2026.
